A carregar...
Intermittent versus Daily Eltrombopag Dosage Protocols for the Treatment of Primary Immune Thrombocytopenia: Real-Life Experience
INTRODUCTION/AIM: Eltrombopag is recommended for the treatment of refractory immune thrombocytopenia (ITP). Based on its half-life, it may be practical to use an intermittent dosage. Our aim was to compare the effectiveness and safety of intermittent vs daily eltrombopag dosage protocols for the tre...
Na minha lista:
| Publicado no: | J Blood Med |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7783199/ https://ncbi.nlm.nih.gov/pubmed/33414648 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/JBM.S289149 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|